Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 10, 2007 - Issue 4
1,361
Views
106
CrossRef citations to date
0
Altmetric
Obesity and Reproductive Health

Impact of Obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines

, &
Pages 195-206 | Published online: 03 Jul 2009

References

  • Al-Azemi M., Omu F. E., Omu A. E. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Archives of Gynecology & Obstetrics 2004; 270(4)205–210
  • Ashton W. D., Nanchahal K., Wood D. A. Body mass index and metabolic risk factors for coronary heart disease in women. European Heart Journal 2001; 22: 46–55
  • Balen A. H., Michelmore K. What is polycystic ovary syndrome? Are national views important?. Human Reproduction 2002; 17: 2219–2227
  • Balen A. H., Dresner M., Scott E. M., Drife J. O. Should obese women with polycystic ovary syndrome (PCOS) receive treatment for infertility?. British Medical Journal 2006; 332: 434–435
  • Balen A. H. Surgical management of PCOS. Polycystic Ovary Syndrome, Best Practice and Research in Clinical Endocrinology and Metabolism, R. Azziz, R. Legro, L. Giudice, 2006; 20: 271–280
  • Maheshwari A., Stofberg L., Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology a systematic review. Human reproduction update 2007; 13: 433–444
  • Bellver J., Rossal L. P., Bosch E., Zuniga A., Corona J. T., Melendez F., Gomez E., Simon C., Remohi J., Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Sterility 2003; 79: 1136–1140
  • Brannian J. D., Schmidt S. M., Kreger D. O., Hansen K. A. Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes. Human Reproduction 2001; 16(9)1819–1826
  • Budak E., Fernandez-Sanchez M., Bellver J., Cervero A., Simon C., Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertility and Sterility 2006; 85: 1563–1581
  • Callaway L. K., Prins J. B., Chang A. M., McIntyre H. D. The prevalence and impact of overweight and obesity in an Australian obstetric population. The Medical Journal of Australia 2006; 184: 56–59
  • Cedergren M. I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obsterics and Gynecology, Clinical endocrinology 2004; 103: 219–224
  • CEMACH: Confidential Enquiry into Maternal and Child Health. Pregnancy in women with Type 1 and Type 2 Diabetes in 2002 – 03, England,Wales and Northern Ireland. CEMACH, London 2005
  • Clark A. M., Ledger W., Galletly C., Tomlinson L., Blaney F., Wang X., Norman R. J. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction 1995; 10: 2705–2712
  • Clark A. M., Thornley B., Tomlinson L., Galletley C., Norman R. J. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502–1505
  • Clark A. M., Roberts B. G. (2000) Maximizing weight loss in the overweight infertile patient: a prospective randomized controlled trial. 16th Annual Meeting of ESHRE, 2000, BolognaItaly, 2000, Abstract No.O-162 Hum Reprod 15(Abstract Book 1): 65 – 66
  • Conn J. J., Jacobs H. S., Conway G. S. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism (Oxf) 2000; 52: 81–86
  • Conway G. S., Clark P. M. S., Wong D. Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Journal of Clinical Endocrinology and Metabolism 1993; 38: 219–222
  • Costello M., Eden J. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertility and Sterility 2003; 79: 1–9
  • Craig L. B., Ke R. W., Kutteh W. H. Increased prevalence of isnsulin resistance in women with a history of recurrent pregnancy loss. Fertility and Sterility 2002; 78: 487–490
  • Crosignani P. G., Ragni G., Parazzini F., Wyssling H., Lombroso G., Perotti L. Anthropometric indicators and response to gonadotrophin for ovulation induction. Human Reproduction 1994; 9(3)420–423
  • Crosignani P. G., Colombo M., Vegetti W., Somigliana E., Gessati A., Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indicies, ovarian physiology and fertility rate induced by diet. Human Reproduction 2003; 18: 1928–1932
  • Dale P. O., Tanbo T., Haug E., Abyholm T. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Human Reproduction 1998; 13(3)567–570
  • Despres J. P., Lemieux I., Prud'homme D. Treatment of obesity: need to focus on high risk, abdominally obese patients. BMJ 2001; 322: 716–720
  • Ehrenberg H. M., Durnwald C. P., Catalano P., Mercer B. M. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol 2004; 191: 969–974
  • Ehrmann D. A., Barnes R. B., Rosenfield R. L., Cavaghan M. K., Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–146
  • ESHRE Capri Workshop Group. Nutrition and reproduction in women. Human Reproduction Update 2006; 12: 193–207
  • Falsetti L., Pasinetti E., Mazzani M. D., Gastaldi A. Weight loss and menstrual cycle: clinical and endocrinological evaluation. Gynecological Endocrinology 1992; 6(1)49–56
  • Farquhar C. M. Prioritising for fertility treatments: should a high body mass index exclude treatment?. BJOG 2006; 113: 1107–1109
  • Fedorcsak P., Storeng R., Dale P. O., Tanbo T., Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000; 79(1)43–48
  • Fedorcsak P., Storeng R., Dale P. O., Tanbo T., Torjesen P., Urbancsek J., Abyholm T. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. Scandinavian Journal of Clinical and Laboratory Investigation 2000; 60(8)649–655
  • Fedorcsak P., Dale P. O., Storeng R., Tanbo T., Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Human Reproduction 2001; 16(6)1086–1091
  • Fedorcsak P., Dale P. O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., Omland A. K., Abyholm T., Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Human Reproduction 2004; 19(11)2523–2528
  • Fedorcsak P., Storeng R., Dale P. O., Tanbo T., Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000; 79(1)43–48
  • Fedorcsak P., et al. Impact of overweight and underweight on assisted reproduction treatment. Human Reproduction 2004; 2523–2528
  • Fleming R., Hopkinson Z., Wallace A., Greer I., Sattar N. Ovarian function and metabolic factors in women with oligomenorrhoea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metabol 2002; 87: 569–574
  • Foreyt J. P., Poston W. S. Obesity: a never-ending cycle?. International Journal of Fertility and Women's Medicine 1998; 43: 111–116
  • Gillett W. R., Putt T., Farquhar C. M. Prioritising for fertility treatments: the effect of excluding women with a high body mass index. BJOG 2006, (in press)
  • Gjoannaess H. The course and outcome of pregnancy after ovarian electrocautery with PCOS: the influence of body weight. Br. J. Obstet. Gynaecol 1989; 96: 714–719
  • Glueck C. J., Awadalla S. G., Phillips H., Cameron D., Wang P., Fontaine R. N. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril 2000; 74: 394–397
  • Gosman G. G., Katcher H. I., Legro R. S. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Updat 2006; 12: 585–601
  • Grodstein F., Goldman M. B., Cramer D. W. Body mass index and ovulatory infertility. Epidemiology 1994; 5(2)247–250
  • Guzick D. S., Wing R., Smith D., Berga S. L., Winters S. J. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994; 61(4)598–604
  • Halme J., Hammond M. G., Talbert L. M., O'Rand M., Bailey L., Sloan C. Positive correlation between body weight, length of human menopausal gonadotropin stimulation, and oocyte fertilization rate. Fertil Steril 1986; 45(3)372–376
  • Hamilton-Fairley, et al. Obesity and miscarriage. Br J O G 1992; 99: 128
  • Hollmann M., Runnebaum B., Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Rreprod 1996; 11(9)1884–1891
  • Homburg R., Orvieto R., Bar-Hava I., Ben-Rafael Z. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Human Reproduction 1996; 11(4)716–719
  • Kanagalingam M. G., Forouhi N. G., Greer I. A., Sattar N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow maternity hospital. BJOG 2005; 112: 1431–1433
  • Kirchengast S., Huber J. Body composition characteristics and fat distribution in young infertile women. F&S 2004; 81: 539–544
  • Koloszar S., Daru J., Kereszturi A., Zavaczki Z., Szollosi J., Pal A. Effect of female body weight on efficiency of donor AI. Archives of Andrology 2002; 48: 323–327
  • Lashen H., Ledger W., Bernal A. L., Barlow D. Extremes of bosy mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Human Reprod 1999; 14: 712–715
  • Lawlor D. A., Bedford C., Taylor M., Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 2003; 57: 134–140
  • Legro R. S., Kunselman A. R., Dodson W. C., Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165–169
  • Legro R. S., Barnhart H. X., Schlaff W. D., Carr B. R., Diamond M. P., Carson S. A., Steinkampf M. P., Coutifaris C., McGovern P. G., Cataldo N. A., Gosman G., Nestler J. E., Giudice L. C., Leppert P. C., Myers E. R., for the Reproductive Medicine Network. Effect of clomiphene and metformin, alone and in combination, on rate of live birth in infertile women with polycystic ovary syndrome. New England Journal of Medicine 2007; 356: 551–566
  • G. Lewis, 2002. Why Mothers Die 2000 – 2002. London, Confidential Enquiry into Maternal and Child Health
  • Linné Y. Effects of obesity on women's reproduction and complications during pregnancy. Obesity reviews 2004; 5: 137–143
  • Lintsen A. M., Pasker-de Jong P. C., de Boer E. J., Burger C. W., Jansen C. A., Braat D. D., van Leeuwen F. E. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Human Reproduction 2005; 20: 1867–1875
  • Lord J., Wilkin T. Polycystic ovary syndrome and fat distribution: the central issue?. Human Fertility 2002; 5: 67–71
  • Lord J. M., Flight I. H., Norman R. J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. The Cochrane Database of Systematic Reviews 2003, 2003, Issue 2. Art. No.: CD003053. DOI: 10.1002/14651858.CD003053
  • Lord J. M., Flight I. H. K., Norman R. J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 2003; 327: 951–955
  • Loveland J. B., McClamrock H. D., Malinow A. M., Sharara F. I. Increased body mass index has a deleterious effect on in vitro fertilization outcome. Journal of Assisted Reproduction and Genetics 2001; 18: 382–386
  • Maciel G. A. R., Junior J. M. S., Motta E. L. A., Haida M. A., Lima G. R., Baracat E. C. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril 2004; 81: 355–360
  • Moll E., Bossuyt P. M., Korevaar J. C., Lambalk C. B., van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ Jun 24, 2006; 332(7556)1485
  • Mulders A. G., Laven J. S., Imani B., Eijkemans M. J., Fauser B. C. IVF outcome in anovulatory infertility (WHO group 2) – including polycystic ovary syndrome – following previous unsuccessful ovulation induction. Reproductive Biomedicine Online 2003; 7(1)50–58
  • Mulders A. G. M. G. J., Laven J. S. E., Eijkemans M. J. C., Hughes E. G., Fauser B. C. J. M. Patient predictors for outcome with gonadotropin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Human Reproduction Update 2003; 9: 429–449
  • National Institute for Clinical Excellence (NICE). Fertility assessment and treatment for people with fertility problems. A clinical guideline. RCOG Press, London 2004
  • Nichols J. E., Crane M. M., Higdon H. L., Miller P. B., Boone W. R. Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertility & Sterility 2003; 79(3)645–647
  • Norman R. J., Noakes M., Wu R., Davies M. J., Moran L., Wang J. X. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 2004; 10: 267–280
  • Norman R. J., Masters L., Milner C. R., Wang J. X., Davies M. J. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Human Reproduction 2001; 16: 1995–1998
  • Pasquali R., Antenucci D., Caimirri F., Venturoli S., Paradis R., Fabbri R. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68: 173–179
  • Radon P. A., McMahon M. J., Meyer W. R. impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94(2)194–197
  • Ramsay J. E., Greer I. A. Obesity in Pregnancy. Fetal and Maternal Medicine Review 2004; 15: 109–132
  • Ramsay J. E., Greer I. A., Sattar N. Obesity and Reproduction. BMJ 2006; 333: 1159–1162
  • Styne-Gross A., et al. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril 2005; 83: 1629–1634
  • Tang T., Glanville J., Hayden C. J., White D., Barth J. H., Balen A. H. Combined life-style modification and metformin in obese patients with PCOS. A randomised, placebo-controlled, double-blind multi-centre study. Human Reproduction 2006; 21: 80–89
  • Villamor E., Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368: 1164–1170
  • Wang J. X., Davies M., Norman R. J. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000; 321: 1320–1321
  • Wang J. X., Davies M., Norman R. J. Obesity increases the risk of sponatneous abortion during infertility treatment. Obesity Research 2002; 10: 551–554
  • Wass P., Waldenstrom U., Rossner S., Hellberg D. An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Human Reproduction 1997; 12: 2057–2060
  • Wijeyaratne C. N., Balen A. H., Barth J., Belchetz P. E. Clinical manifestations and insulin resistance (IR) in PCOS among South Asians and Caucasians: is there a difference?. Clinical Endocrinology 2002; 57: 343–350
  • Wild S., Pierpoint T., Jacobs H., McKeigue P. Long-term consequences of PCOS: results of a 31 year follow-up study. Hum Fertil 2000; 3: 101–105
  • Wittemer C., Ohl J., Bailly M., Bettahar-Lebugle K., Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome?. Journal of Assisted Reproduction & Genetics 2000; 17: 547–552
  • Wolfe H. High prepregnancy body-mass index — a maternal – fetal risk factor. The New England Journal of Medicine 1998; 338: 191–192
  • Yu C. K. H., Teoh T. G., Robinson S. Obesity in Pregnancy. BJOG 2006; 113: 1117–1125
  • Zaadstra B. M., Seidell J. C., Van Noord P. A. H., te Velde E. R., Habbema J. D. F., Vrieswijk B., Karbaat J. Fat and female fecundity:prospective study of effect of body fat distribution on coneption rates. BMJ 1993; 305: 484–487
  • Zachariah M., Fleming R., Acharya U. Management of obese women in assisted conception units: A UK survey. Human Fertility 2006; 9: 101–105

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.